{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:16:40Z","timestamp":1794971800636,"version":"4.9.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-021185"],"award-info":[{"award-number":["MJFF-021185"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-021185"],"award-info":[{"award-number":["MJFF-021185"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aging is the main risk factor for Parkinson\u2019s disease (PD), yet our understanding of how age-related mechanisms contribute to PD pathophysiology remains limited. We conducted a longitudinal analysis of blood samples from the Parkinson\u2019s Progression Markers Initiative cohort to investigate DNA damage in PD. Patients with PD exhibited disrupted DNA repair pathways and biased suppression of longer transcripts, indicating age-related, transcription-stalling DNA damage. Notably, at the intake visit, this DNA damage signature was detected only in patients with more severe progression of motor symptoms over 3 years, suggesting its potential as a predictor of disease severity. We validated this signature in independent PD cohorts and confirmed increased DNA damage in peripheral blood cells and dopamine neurons of the substantia nigra pars compacta in postmortem PD brains. Our study sheds light on an aging-related mechanism in PD pathogenesis and identifies potential markers of disease progression, providing a diagnostic platform to prognosticate disease progression.<\/jats:p>","DOI":"10.1038\/s43587-025-00926-x","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T09:02:12Z","timestamp":1757062932000},"page":"1844-1861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A blood-based DNA damage signature in patients with Parkinson\u2019s disease is associated with disease progression"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-683X","authenticated-orcid":false,"given":"Daisy","family":"Sproviero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Pay\u00e1n-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8696-2603","authenticated-orcid":false,"given":"Chiara","family":"Milanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Barnhoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5499-2963","authenticated-orcid":false,"given":"Shixiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akos","family":"Gyenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Delia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7389-0348","authenticated-orcid":false,"given":"Tammaryn","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3526-7795","authenticated-orcid":false,"given":"Jan H. J.","family":"Hoeijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8457-9595","authenticated-orcid":false,"given":"Jan","family":"Vijg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2364-4258","authenticated-orcid":false,"given":"Pier G.","family":"Mastroberardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"926_CR1","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primers 3, 17013 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"926_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncl.2014.09.010","volume":"33","author":"S Mullin","year":"2015","unstructured":"Mullin, S. & Schapira, A. H. V. Pathogenic mechanisms of neurodegeneration in Parkinson disease. Neurol. Clin. 33, 1\u201317 (2015).","journal-title":"Neurol. Clin."},{"key":"926_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/PL00007856","volume":"249","author":"T Foltynie","year":"2002","unstructured":"Foltynie, T., Brayne, C. & Barker, R. A. The heterogeneity of idiopathic Parkinson\u2019s disease. J. Neurol. 249, 138\u2013145 (2002).","journal-title":"J. Neurol."},{"key":"926_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg, D. et al. Prodromal Parkinson disease subtypes\u2014key to understanding heterogeneity. Nat. Rev. Neurol. 17, 349\u2013361 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"926_CR5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00702-016-1667-6","volume":"124","author":"N Titova","year":"2017","unstructured":"Titova, N., Padmakumar, C., Lewis, S. J. G. & Chaudhuri, K. R. Parkinson\u2019s: a syndrome rather than a disease? J. Neural Transm. (Vienna) 124, 907\u2013914 (2017).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"926_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1212\/WNL.0b013e3181ae7af1","volume":"73","author":"AH Rajput","year":"2009","unstructured":"Rajput, A. H., Voll, A., Rajput, M. L., Robinson, C. A. & Rajput, A. Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 73, 206\u2013212 (2009).","journal-title":"Neurology"},{"key":"926_CR7","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/mds.26371","volume":"30","author":"K Kieburtz","year":"2015","unstructured":"Kieburtz, K. & Olanow, C. W. Advances in clinical trials for movement disorders. Mov. Disord. 30, 1580\u20131587 (2015).","journal-title":"Mov. Disord."},{"key":"926_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.07.019","volume":"32","author":"D Athauda","year":"2016","unstructured":"Athauda, D. & Foltynie, T. Challenges in detecting disease modification in Parkinson\u2019s disease clinical trials. Parkinsonism Relat. Disord. 32, 1\u201311 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"926_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrn3039","volume":"12","author":"TJ Collier","year":"2011","unstructured":"Collier, T. J., Kanaan, N. M. & Kordower, J. H. Ageing as a primary risk factor for Parkinson\u2019s disease: evidence from studies of non-human primates. Nat. Rev. Neurosci. 12, 359\u2013366 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"926_CR10","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMra0804615","volume":"361","author":"JHJ Hoeijmakers","year":"2009","unstructured":"Hoeijmakers, J. H. J. DNA damage, aging, and cancer. N. Engl. J. Med. 361, 1475\u20131485 (2009).","journal-title":"N. Engl. J. Med."},{"key":"926_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pneurobio.2011.04.013","volume":"94","author":"DK Jeppesen","year":"2011","unstructured":"Jeppesen, D. K., Bohr, V. A. & Stevnsner, T. DNA repair deficiency in neurodegeneration. Prog. Neurobiol. 94, 166\u2013200 (2011).","journal-title":"Prog. Neurobiol."},{"key":"926_CR12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41586-021-03307-7","volume":"592","author":"B Schumacher","year":"2021","unstructured":"Schumacher, B., Pothof, J., Vijg, J. & Hoeijmakers, J. H. J. The central role of DNA damage in the ageing process. Nature 592, 695\u2013703 (2021).","journal-title":"Nature"},{"key":"926_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2020.06.024","volume":"182","author":"J Vijg","year":"2020","unstructured":"Vijg, J. & Dong, X. Pathogenic mechanisms of somatic mutation and genome mosaicism in aging. Cell 182, 12\u201323 (2020).","journal-title":"Cell"},{"key":"926_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1126\/science.aao4426","volume":"359","author":"MA Lodato","year":"2018","unstructured":"Lodato, M. A. et al. Aging and neurodegeneration are associated with increased mutations in single human neurons. Science 359, 555\u2013559 (2018).","journal-title":"Science"},{"key":"926_CR15","doi-asserted-by":"publisher","first-page":"102669","DOI":"10.1016\/j.dnarep.2019.102669","volume":"81","author":"AA Abugable","year":"2019","unstructured":"Abugable, A. A. et al. DNA repair and neurological disease: from molecular understanding to the development of diagnostics and model organisms. DNA Repair (Amst.) 81, 102669 (2019).","journal-title":"DNA Repair (Amst.)"},{"key":"926_CR16","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.celrep.2016.04.071","volume":"15","author":"S Sepe","year":"2016","unstructured":"Sepe, S. et al. Inefficient DNA repair is an aging-related modifier of Parkinson\u2019s disease. Cell Rep. 15, 1866\u20131875 (2016).","journal-title":"Cell Rep."},{"key":"926_CR17","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41419-018-0848-7","volume":"9","author":"C Milanese","year":"2018","unstructured":"Milanese, C. et al. Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson\u2019s disease. Cell Death Dis. 9, 818 (2018).","journal-title":"Cell Death Dis."},{"key":"926_CR18","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat. Genet. 46, 989\u2013993 (2014).","journal-title":"Nat. Genet."},{"key":"926_CR19","doi-asserted-by":"publisher","first-page":"e1002548","DOI":"10.1371\/journal.pgen.1002548","volume":"8","author":"CM Lill","year":"2012","unstructured":"Lill, C. M. et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson\u2019s disease genetics: the PDGene database. PLoS Genet. 8, e1002548 (2012).","journal-title":"PLoS Genet."},{"key":"926_CR20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/jnen\/63.10.1048","volume":"63","author":"M Hayashi","year":"2004","unstructured":"Hayashi, M. et al. Brainstem and basal ganglia lesions in xeroderma pigmentosum group A. J. Neuropathol. Exp. Neurol. 63, 1048\u20131057 (2004).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"926_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.braindev.2009.09.008","volume":"32","author":"R Miyata","year":"2010","unstructured":"Miyata, R. et al. Low-dose levodopa is effective for laryngeal dystonia in xeroderma pigmentosum group A. Brain Dev. 32, 685\u2013687 (2010).","journal-title":"Brain Dev."},{"key":"926_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"926_CR23","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s43587-021-00088-6","volume":"1","author":"DW Craig","year":"2021","unstructured":"Craig, D. W. et al. RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson\u2019s disease. Nat. Aging 1, 734\u2013747 (2021).","journal-title":"Nat. Aging"},{"key":"926_CR24","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1093\/bioinformatics\/bth456","volume":"20","author":"EI Boyle","year":"2004","unstructured":"Boyle, E. I. et al. GO::TermFinder\u2014open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 20, 3710\u20133715 (2004).","journal-title":"Bioinformatics"},{"key":"926_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12864-021-07502-8","volume":"22","author":"PD Karp","year":"2021","unstructured":"Karp, P. D., Midford, P. E., Caspi, R. & Khodursky, A. Pathway size matters: the influence of pathway granularity on over-representation (enrichment analysis) statistics. BMC Genomics 22, 191 (2021).","journal-title":"BMC Genomics"},{"key":"926_CR26","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic, M. et al. The Reactome Pathway Knowledgebase 2024. Nucleic Acids Res. 52, D672\u2013D678 (2024).","journal-title":"Nucleic Acids Res."},{"key":"926_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) Hallmark Gene Set Collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"926_CR28","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"926_CR29","doi-asserted-by":"publisher","first-page":"D679","DOI":"10.1093\/nar\/gkad960","volume":"52","author":"A Agrawal","year":"2024","unstructured":"Agrawal, A. et al. WikiPathways 2024: next generation pathway database. Nucleic Acids Res. 52, D679\u2013D689 (2024).","journal-title":"Nucleic Acids Res."},{"key":"926_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"926_CR31","doi-asserted-by":"publisher","unstructured":"The Gene Ontology Consortium et al. The Gene Ontology knowledgebase in 2023. Genetics https:\/\/doi.org\/10.1093\/genetics\/iyad031 (2023).","DOI":"10.1093\/genetics\/iyad031"},{"key":"926_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"926_CR33","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1038\/s41467-023-39652-6","volume":"14","author":"K Irmady","year":"2023","unstructured":"Irmady, K. et al. Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson\u2019s disease. Nat. Commun. 14, 3956 (2023).","journal-title":"Nat. Commun."},{"key":"926_CR34","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"926_CR35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41588-022-01279-6","volume":"55","author":"A Gyenis","year":"2023","unstructured":"Gyenis, A. et al. Genome-wide RNA polymerase stalling shapes the transcriptome during aging. Nat. Genet. 55, 268\u2013279 (2023).","journal-title":"Nat. Genet."},{"key":"926_CR36","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41580-019-0169-4","volume":"20","author":"H Lans","year":"2019","unstructured":"Lans, H., Hoeijmakers, J. H. J., Vermeulen, W. & Marteijn, J. A. The DNA damage response to transcription stress. Nat. Rev. Mol. Cell Biol. 20, 766\u2013784 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"926_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JPD-150738","volume":"6","author":"I Martin","year":"2016","unstructured":"Martin, I. Decoding Parkinson\u2019s disease pathogenesis: the role of deregulated mRNA translation. J. Parkinsons Dis. 6, 17\u201327 (2016).","journal-title":"J. Parkinsons Dis."},{"key":"926_CR38","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson, C. L. et al. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov. Disord. 25, 2649\u20132653 (2010).","journal-title":"Mov. Disord."},{"key":"926_CR39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/ije\/dyw040","volume":"45","author":"S Greenland","year":"2016","unstructured":"Greenland, S., Daniel, R. & Pearce, N. Outcome modelling strategies in epidemiology: traditional methods and basic alternatives. Int. J. Epidemiol. 45, 565\u2013575 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"926_CR40","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1182\/blood-2006-08-041830","volume":"109","author":"J-J Chen","year":"2007","unstructured":"Chen, J.-J. Regulation of protein synthesis by the heme-regulated eIF2\u03b1 kinase: relevance to anemias. Blood 109, 2693\u20132699 (2007).","journal-title":"Blood"},{"key":"926_CR41","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/jnnp-2019-320394","volume":"90","author":"M Avenali","year":"2019","unstructured":"Avenali, M. et al. Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study. J. Neurol. Neurosurg. Psychiatry 90, 1091\u20131097 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"926_CR42","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00415-021-10713-4","volume":"269","author":"M Leocadi","year":"2022","unstructured":"Leocadi, M. et al. Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson\u2019s disease patients. J. Neurol. 269, 1485\u20131500 (2022).","journal-title":"J. Neurol."},{"key":"926_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1749-6632.2000.tb06639.x","volume":"908","author":"T von Zglinicki","year":"2000","unstructured":"von Zglinicki, T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann. N. Y. Acad. Sci. 908, 99\u2013110 (2000).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"926_CR44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature19329","volume":"537","author":"WP Vermeij","year":"2016","unstructured":"Vermeij, W. P. et al. Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice. Nature 537, 427\u2013431 (2016).","journal-title":"Nature"},{"key":"926_CR45","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1038\/s41467-019-12640-5","volume":"10","author":"C Milanese","year":"2019","unstructured":"Milanese, C. et al. DNA damage and transcription stress cause ATP-mediated redesign of metabolism and potentiation of anti-oxidant buffering. Nat. Commun. 10, 4887 (2019).","journal-title":"Nat. Commun."},{"key":"926_CR46","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s43587-022-00317-6","volume":"2","author":"T Stoeger","year":"2022","unstructured":"Stoeger, T. et al. Aging is associated with a systemic length-associated transcriptome imbalance. Nat. Aging 2, 1191\u20131206 (2022).","journal-title":"Nat. Aging"},{"key":"926_CR47","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc.2017.52","volume":"17","author":"TW Glover","year":"2017","unstructured":"Glover, T. W., Wilson, T. E. & Arlt, M. F. Fragile sites in cancer: more than meets the eye. Nat. Rev. Cancer 17, 489\u2013501 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"926_CR48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev.genet.41.042007.165900","volume":"41","author":"SG Durkin","year":"2007","unstructured":"Durkin, S. G. & Glover, T. W. Chromosome fragile sites. Annu. Rev. Genet. 41, 169\u2013192 (2007).","journal-title":"Annu. Rev. Genet."},{"key":"926_CR49","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1186\/s12864-018-5330-5","volume":"19","author":"R Kumar","year":"2019","unstructured":"Kumar, R. et al. HumCFS: a database of fragile sites in human chromosomes. BMC Genomics 19, 985 (2019).","journal-title":"BMC Genomics"},{"key":"926_CR50","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41419-024-06617-6","volume":"15","author":"S Barnhoorn","year":"2024","unstructured":"Barnhoorn, S. et al. Orthogonal analysis of mitochondrial function in Parkinson\u2019s disease patients. Cell Death Dis. 15, 243 (2024).","journal-title":"Cell Death Dis."},{"key":"926_CR51","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/mds.27723","volume":"34","author":"C Milanese","year":"2019","unstructured":"Milanese, C. et al. Peripheral mitochondrial function correlates with clinical severity in idiopathic Parkinson\u2019s disease. Mov. Disord. 34, 1192\u20131202, (2019).","journal-title":"Mov. Disord."},{"key":"926_CR52","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).","journal-title":"Nat. Commun."},{"key":"926_CR53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41398-021-01378-8","volume":"11","author":"C Rodriguez-Fontenla","year":"2021","unstructured":"Rodriguez-Fontenla, C. & Carracedo, A. UTMOST, a single and cross-tissue TWAS (transcriptome wide association study), reveals new ASD (autism spectrum disorder) associated genes. Transl. Psychiatry 11, 256 (2021).","journal-title":"Transl. Psychiatry"},{"key":"926_CR54","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1212\/WNL.0000000000004516","volume":"89","author":"R Shamir","year":"2017","unstructured":"Shamir, R. et al. Analysis of blood-based gene expression in idiopathic Parkinson disease. Neurology 89, 1676\u20131683 (2017).","journal-title":"Neurology"},{"key":"926_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12920-016-0164-y","volume":"9","author":"A Dumitriu","year":"2016","unstructured":"Dumitriu, A. et al. Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease. BMC Med. Genomics 9, 5 (2016).","journal-title":"BMC Med. Genomics"},{"key":"926_CR56","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1101\/gad.301325.117","volume":"31","author":"PJ McKinnon","year":"2017","unstructured":"McKinnon, P. J. Genome integrity and disease prevention in the nervous system. Genes Dev. 31, 1180\u20131194 (2017).","journal-title":"Genes Dev."},{"key":"926_CR57","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.dnarep.2013.04.009","volume":"12","author":"S Sepe","year":"2013","unstructured":"Sepe, S., Payan-Gomez, C., Milanese, C., Hoeijmakers, J. H. & Mastroberardino, P. G. Nucleotide excision repair in chronic neurodegenerative diseases. DNA Repair (Amst.) 12, 568\u2013577, (2013).","journal-title":"DNA Repair (Amst.)"},{"key":"926_CR58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/jnr.24592","volume":"99","author":"CP Gonzalez-Hunt","year":"2021","unstructured":"Gonzalez-Hunt, C. P. & Sanders, L. H. DNA damage and repair in Parkinson\u2019s disease: recent advances and new opportunities. J. Neurosci. Res. 99, 180\u2013189 (2021).","journal-title":"J. Neurosci. Res."},{"key":"926_CR59","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell, A. M. & Youle, R. J. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 85, 257\u2013273 (2015).","journal-title":"Neuron"},{"key":"926_CR60","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.nbd.2014.06.014","volume":"70","author":"LH Sanders","year":"2014","unstructured":"Sanders, L. H. et al. Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson\u2019s disease. Neurobiol. Dis. 70, 214\u2013223 (2014).","journal-title":"Neurobiol. Dis."},{"key":"926_CR61","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","volume":"72","author":"S-M Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad, S.-M. et al. New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol. 72, 863\u2013873 (2015).","journal-title":"JAMA Neurol."},{"key":"926_CR62","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neulet.2012.04.019","volume":"516","author":"M Kosicek","year":"2012","unstructured":"Kosicek, M., Zetterberg, H., Andreasen, N., Peter-Katalinic, J. & Hecimovic, S. Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer\u2019s disease. Neurosci. Lett. 516, 302\u2013305 (2012).","journal-title":"Neurosci. Lett."},{"key":"926_CR63","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/mds.104","volume":"33","author":"AM Smith","year":"2018","unstructured":"Smith, A. M. et al. Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson\u2019s blood cells. Mov. Disord. 33, 1580\u20131590 (2018).","journal-title":"Mov. Disord."},{"key":"926_CR64","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00401-023-02597-7","volume":"146","author":"C Cappelletti","year":"2023","unstructured":"Cappelletti, C. et al. Transcriptomic profiling of Parkinson\u2019s disease brains reveals disease stage specific gene expression changes. Acta Neuropathol. 146, 227\u2013244 (2023).","journal-title":"Acta Neuropathol."},{"key":"926_CR65","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/s41467-024-49949-9","volume":"15","author":"A Zarkali","year":"2024","unstructured":"Zarkali, A., Thomas, G. E. C., Zetterberg, H. & Weil, R. S. Neuroimaging and fluid biomarkers in Parkinson\u2019s disease in an era of targeted interventions. Nat. Commun. 15, 5661 (2024).","journal-title":"Nat. Commun."},{"key":"926_CR66","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf, A. et al. Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 22, 407\u2013417 (2023).","journal-title":"Lancet Neurol."},{"key":"926_CR67","doi-asserted-by":"publisher","first-page":"eabo1557","DOI":"10.1126\/scitranslmed.abo1557","volume":"15","author":"R Qi","year":"2023","unstructured":"Qi, R. et al. A blood-based marker of mitochondrial DNA damage in Parkinson\u2019s disease. Sci. Transl. Med. 15, eabo1557 (2023).","journal-title":"Sci. Transl. Med."},{"key":"926_CR68","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nbd.2013.10.013","volume":"62","author":"LH Sanders","year":"2014","unstructured":"Sanders, L. H. et al. LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson\u2019s disease patients: reversal by gene correction. Neurobiol. Dis. 62, 381\u2013386 (2014).","journal-title":"Neurobiol. Dis."},{"key":"926_CR69","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","volume":"560","author":"U Ben-David","year":"2018","unstructured":"Ben-David, U. et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature 560, 325\u2013330 (2018).","journal-title":"Nature"},{"key":"926_CR70","doi-asserted-by":"publisher","first-page":"105663","DOI":"10.1016\/j.nbd.2022.105663","volume":"166","author":"ME Gegg","year":"2022","unstructured":"Gegg, M. E., Menozzi, E. & Schapira, A. H. V. Glucocerebrosidase-associated Parkinson disease: pathogenic mechanisms and potential drug treatments. Neurobiol. Dis. 166, 105663 (2022).","journal-title":"Neurobiol. Dis."},{"key":"926_CR71","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson III","year":"2023","unstructured":"Wilson, D. M. III et al. Hallmarks of neurodegenerative diseases. Cell 186, 693\u2013714 (2023).","journal-title":"Cell"},{"key":"926_CR72","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41531-019-0076-6","volume":"5","author":"RH Reynolds","year":"2019","unstructured":"Reynolds, R. H. et al. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson\u2019s disease heritability. NPJ Parkinsons Dis. 5, 6 (2019).","journal-title":"NPJ Parkinsons Dis."},{"key":"926_CR73","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrm.2016.14","volume":"17","author":"EF Fang","year":"2016","unstructured":"Fang, E. F. et al. Nuclear DNA damage signalling to mitochondria in ageing. Nat. Rev. Mol. Cell Biol. 17, 308\u2013321 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"926_CR74","doi-asserted-by":"publisher","first-page":"103155","DOI":"10.1016\/j.dnarep.2021.103155","volume":"105","author":"TT Paull","year":"2021","unstructured":"Paull, T. T. DNA damage and regulation of protein homeostasis. DNA Repair (Amst.) 105, 103155 (2021).","journal-title":"DNA Repair (Amst.)"},{"key":"926_CR75","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/ncb1909","volume":"11","author":"F Rodier","year":"2009","unstructured":"Rodier, F. et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11, 973\u2013979 (2009).","journal-title":"Nat. Cell Biol."},{"key":"926_CR76","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41584-022-00905-1","volume":"19","author":"A Pezone","year":"2023","unstructured":"Pezone, A. et al. Inflammation and DNA damage: cause, effect or both. Nat. Rev. Rheumatol. 19, 200\u2013211, (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"926_CR77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41577-022-00751-y","volume":"23","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y., Simon, M., Seluanov, A. & Gorbunova, V. DNA damage and repair in age-related inflammation. Nat. Rev. Immunol. 23, 75\u201389 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"926_CR78","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1101\/sqb.2000.65.127","volume":"65","author":"T Lindahl","year":"2000","unstructured":"Lindahl, T. & Barnes, D. E. Repair of endogenous DNA damage. Cold Spring Harb. Symp. Quant. Biol. 65, 127\u2013133 (2000).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"926_CR79","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/carcin\/bgp262","volume":"31","author":"N Shrivastav","year":"2010","unstructured":"Shrivastav, N., Li, D. & Essigmann, J. M. Chemical biology of mutagenesis and DNA repair: cellular responses to DNA alkylation. Carcinogenesis 31, 59\u201370 (2010).","journal-title":"Carcinogenesis"},{"key":"926_CR80","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tig.2008.07.003","volume":"24","author":"S Feuerhahn","year":"2008","unstructured":"Feuerhahn, S. & Egly, J.-M. Tools to study DNA repair: what\u2019s in the box? Trends Genet. 24, 467\u2013474 (2008).","journal-title":"Trends Genet."},{"key":"926_CR81","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s12864-021-08009-y","volume":"22","author":"KC Paul","year":"2021","unstructured":"Paul, K. C. et al. Accelerated hematopoietic mitotic aging measured by DNA methylation, blood cell lineage, and Parkinson\u2019s disease. BMC Genomics 22, 696 (2021).","journal-title":"BMC Genomics"},{"key":"926_CR82","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/bioinformatics\/bty019","volume":"34","author":"F Avila Cobos","year":"2018","unstructured":"Avila Cobos, F., Vandesompele, J., Mestdagh, P. & De Preter, K. Computational deconvolution of transcriptomics data from mixed cell populations. Bioinformatics 34, 1969\u20131979 (2018).","journal-title":"Bioinformatics"},{"key":"926_CR83","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","volume":"35","author":"A Zhu","year":"2019","unstructured":"Zhu, A., Ibrahim, J. G. & Love, M. I. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics 35, 2084\u20132092 (2019).","journal-title":"Bioinformatics"},{"key":"926_CR84","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"926_CR85","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"926_CR86","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."},{"key":"926_CR87","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2164-10-22","volume":"10","author":"D Smedley","year":"2009","unstructured":"Smedley, D. et al. BioMart\u2014biological queries made easy. BMC Genomics 10, 22 (2009).","journal-title":"BMC Genomics"},{"key":"926_CR88","doi-asserted-by":"publisher","unstructured":"Meeker, A. K., Heaphy, C. M., Davis, C. M., Roy, S. & Platz, E. A. Photochemical pre-bleaching of formalin-fixed archival prostate tissues significantly reduces autofluorescence to facilitate multiplex immunofluorescence staining. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.11.09.467916 (2021).","DOI":"10.1101\/2021.11.09.467916"},{"key":"926_CR89","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1038\/s41596-019-0206-y","volume":"14","author":"Z Du","year":"2019","unstructured":"Du, Z. et al. Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging. Nat. Protoc. 14, 2900\u20132930 (2019).","journal-title":"Nat. Protoc."},{"key":"926_CR90","doi-asserted-by":"publisher","unstructured":"Sproviero, D. et al. DNAdamageinPD\/Natureageing: Minor update to trigger Zenodo DOI3 (v1.0.3). Zenodo https:\/\/doi.org\/10.5281\/zenodo.16728586 (2025).","DOI":"10.5281\/zenodo.16728586"}],"updated-by":[{"DOI":"10.1038\/s43587-025-01037-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000}}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00926-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00926-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00926-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:03:09Z","timestamp":1763625789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00926-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":90,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1038\/s43587-025-00926-x","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"18 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s43587-025-01037-3","URL":"https:\/\/doi.org\/10.1038\/s43587-025-01037-3","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.G.M. is an inventor on a patent application related to the use of a DNA damage molecular signature in the blood for prognostic purposes in Parkinson\u2019s disease. J.V. is a founder and shareholder of MutaGentech, Inc. D.S., C.P.-G., C.M., S.B., S.S., A.G., D.D., T.L. and J.H.J.H. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}